This shift matters because the pharmaceutical industry carries material weight. The sector is estimated to be responsible for ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the ...

With only two weeks left of U.S. Congress in session, a final push for a consensus on healthcare is underway. Both Democrats and Republicans ...

This week has been traumatising. I woke up this morning and turned on the radio, as I always do, and was greeted by ...

The trial, conducted in Bangladesh in partnership with the International Centre for Diarrhoeal Disease Research, Bangladesh ...

It has long been hailed as the ultimate productivity hack, but pulling up your sheets might be trapping you with millions of ...

In the final days of the Biden Administration, the EPA locked in a formaldehyde risk evaluation built on the Agency’s ...

The convergence of disease threats, including Covid, flu, RSV and norovirus threatens to overwhelm hospitals, disrupt ...

Rep. Gus Bilirakis, a Palm Harbor Republican who chairs the House Commerce, Manufacturing and Trade Subcommittee, introduced ...

The denim case reveals the deeper moral collapse of Bangladesh's economic system. In compassionate capitalism, the 60/40 structure supports social trust, innovation, and reinvestment. In Bangladesh, ...

On December 3, 2025, the U.S. Environmental Protection Agency (EPA) announced the availability of and solicited public comment on an Updated Draft Risk Calculation Memorandum (Draft Memorandum) to ...

Coherus Oncology, Inc. (NASDAQ: CHRS) today announced compelling six-year overall survival (OS) follow-up results from the Phase 3 JUPITER-02 trial evaluating LOQTORZI® (toripalimab-tpzi) plus ...